D. Peest - Concepedia

Author

D. Peest

Medizinische Hochschule Hannover

Also Known As

Bernd Metzner, D Peest, D. PEEST, D. Peest, DIETRICH PEEST, Dietrich Peest, Dietrich Peest (494675)

100

Publications

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover University of Tübingen University Hospital Ulm Klinikum Oldenburg Klinikum Arnsberg

About

D. Peest is an author at Medizinische Hochschule Hannover specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.2K
2	Health Sciences	6	6	164
3	Cell Biology	6	6	253
4	Allergy	3	3	134
5	Epidemiology	1	1	26

D. Peest

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials Stefano Pasquali, J D Maqueo, Jorge Espino Vela, Oxford University Research Archive (ORA) (University of Oxford) Hematological MalignancyOncologyMetronomic TherapyImmunologyRandomized Trials	1998	473
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma Anders Österborg, MA Boogaerts, R Cimino, Blood	1996	206
Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells R. Leo, Martin Boeker, D. Peest, Annals of Hematology Hematological MalignancyTumor BiologyMalignant Blood DisorderImmunologyHematology	1992	112
T Cells in Monoclonal Gammopathies Hákan Mellstedt, G. Holm, D Pettersson, Scandinavian Journal of Haematology Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseAllergyT Cells	1982	89
Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer Anke Franzke, D. Peest, Michael Probst‐Kepper, Journal of Clinical Oncology	1999	88
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group D. Peest, H. Deicher, R. Coldewey, European Journal of Cancer Hematological MalignancyMedicineImmunologyHematologyMyeloid Neoplasia	1995	73
Idiotype-bearing Lymphoid Cells in Plasma Cell Neoplasia Håkan Mellstedt, Göran Holm, D Pettersson, Clinics in Haematology Lymphoid NeoplasiaMalignant Blood DisorderImmunologyHistopathologyPathology	1982	61
Palliative radiotherapy in plasma cell myeloma Irenäus A. Adamietz, C. Schöber, R. Schulte, Radiotherapy and Oncology Hematological MalignancyRadiation TherapyMedicineMalignant Blood DisorderHematology	1991	51
Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients* M. Sailer, K. F. Vykoupil, D. Peest, European Journal Of Haematology	1995	48
Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS‐to‐MAP kinase signalling in multiple myeloma cells Michael Morgan, Tarkan Sebil, Erdem Aydilek, British Journal of Haematology	2005	47

Page 1